Perioperative corticosteroids and pancreatic surgery outcomes: a systematic review and meta-analysis combining human expertise and AI support (ChatGPT) - Report - MDSpire

Perioperative corticosteroids and pancreatic surgery outcomes: a systematic review and meta-analysis combining human expertise and AI support (ChatGPT)

  • By

  • Marcello Di Martino

  • Andrea Saibanti

  • Gianluca Cassese

  • Mariantonietta Alagia

  • Fabrizio Panaro

  • Matteo Donadon

  • July 8, 2026

  • 0 min

Share

Impact of Perioperative Corticosteroid Administration on Outcomes in Pancreatic Surgery

Overview

This systematic review and meta-analysis evaluates the role of perioperative corticosteroids in pancreatic surgery, focusing on their impact on postoperative outcomes such as clinically relevant postoperative pancreatic fistula (CR-POPF) and surgical site infections (SSI). Current evidence regarding the benefits of corticosteroid administration in this surgical context is not definitive.

Background

Postoperative complications following pancreatic surgery, including CR-POPF and infectious complications, contribute significantly to morbidity and mortality. Despite advancements in surgical techniques and perioperative care, complication rates remain high. The use of corticosteroids has been explored for their potential to reduce inflammation and improve outcomes, yet their role in pancreatic surgery is still debated.

Data Highlights

The source material did not provide numerical data or trial results.

Key Findings

  • Postoperative complications after pancreatic surgery occur in 30-50% of cases.
  • Corticosteroids may modulate inflammatory responses, potentially impacting CR-POPF development.
  • Current clinical practice regarding corticosteroid use in pancreatic surgery varies significantly.
  • Previous systematic reviews on this topic have reported inconsistent results.
  • No international guidelines currently recommend routine perioperative corticosteroid use in pancreatic surgery.

Clinical Implications

Further research is needed to establish standardized protocols for corticosteroid administration in this context.

Conclusion

Current evidence does not support definitive conclusions regarding the efficacy of perioperative corticosteroids in pancreatic surgery.

Related Resources & Content

  1. Updates in Surgery, 2025 -- The Impact of Perioperative Hydrocortisone on Morbidity Following Pancreatoduodenectomy: An Analysis Using Propensity Score Matching
  2. Frontiers in Surgery, 2026 -- The role of artificial intelligence in postoperative clinical decision-making for pancreatic cancer: a pilot study
  3. Systematic Review and Meta-Analysis of Analgesic Approaches for Managing Postoperative Pain Following Pancreatic Resection, 2021
  4. The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After - Surgery
  5. The Effect of Perioperative Dexamethasone on Postoperative Complications After Pancreaticoduodenectomy: A Multicenter Randomized Controlled Trial - PubMed
  6. Obesity Surgery — Recent Uses of Artificial Intelligence in the Field of Bariatric Surgery
  7. The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After - Surgery
  8. The Effect of Perioperative Dexamethasone on Postoperative Complications After Pancreaticoduodenectomy: A Multicenter Randomized Controlled Trial - PubMed
  9. Guidelines for Perioperative Care for Pancreatoduodenectomy: Enhanced Recovery After Surgery (ERAS) Recommendations 2019
  10. The 2024 Korean Enhanced Recovery After Surgery guidelines for hepatobiliary and pancreatic surgery

Original Source(s)

Related Content